ARTICLE | Regulation Agency moves toward relaxing restrictions on untested peptides
By Steve Usdin, Washington Editor
April 16, 2026 12:53 AM UTC
Responding to...
In a groundbreaking study published recently, researchers have begun to unravel the transformative potential of genomics-guided off-label treatments in cancer care, shining a light...
Across antibody therapeutics, cell and gene therapies, oligonucleotide drugs, industrial enzymes, and AI-driven molecular design, securing core genetic sequences is now a key factor...
Beeline Medicines emerged from stealth Wednesday with plans to develop “precision therapies” for immune diseases, nearly a year after its backer Bain Capital teamed...